2026 NPPES data Optometrist NPI 1790979102
Verify on CMS →

Molly Wood

Optometrist in State College, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
391
Medicare Part D claims · 140 beneficiaries · Optometrist avg: 257
Generic prescribing
52%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
73.6/100
▼ 9 pts below national avg 83.1 · [object Object]

What the federal data shows

Molly Wood reported a CMS MIPS final score of 73.6/100 — below the 83.1 national average — and filed 391 Medicare Part D claims in 2023.

73.6/100
MIPS score · -9 vs avg
391
Part D claims, 2023
52%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Molly Wood's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

74 11th percentile higher than 11% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about Molly Wood?

Below national average

NPI registry status

Active

Issued 08/29/2007

NPI 1790979102

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

391 52% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

73.6/100 9.5 pts vs avg

Mid-tier band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Optometrist compares to other specialties among Pennsylvania providers

Pennsylvania providers

Optometrist share within Pennsylvania

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Pennsylvania

Medicare quality performance — MIPS

Molly Wood's 2023 MIPS final score plotted against the Optometrist national average

Below national average
MIPS Final Score
73.6/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 73.6/100 vs national avg 83.1

0%100%National avg83%73.6%
MIPS final score (Optometrist) — 73.6/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Molly Wood appears in the CMS NPPES registry as a Optometrist provider at 2581 CLYDE AVE, State College, PA, 16801, with a listed phone of (814) 867-5415. NPI 1790979102 was issued on 08/29/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Wood most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 391 prescription claims written by this provider, covering 140 Medicare beneficiaries and totaling roughly $87K in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.6/100 for the 2023 performance year (Quality 100, Cost 12), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2581 CLYDE AVE
State College, PA 16801

Provider Details

NPI 1790979102
Specialty Optometrist
Gender Female
NPI Issued 08/29/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

73.6051
Final Score
Avg: 83.1
100
Quality
12.0171
Cost

Reporting: Group practice

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to Molly Wood. To verify Molly Wood's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Molly Wood — brand share 48.0%
Specialty average (est.)

48% brand-name claims vs 52% generic, on 391 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

391
Total Claims
$87K
Total Drug Cost
140
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
713
Total Day Supply
19,609
Brand vs Generic
48% brand / 52% generic
Brand Drug Cost
$80K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
78.5 years
Avg HCC Risk Score
1.16
Gender Split
67% female / 33% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Molly Wood prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Timolol Maleate
66
Latanoprost
47
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
40
Prednisolone Acetate
40
Lumigan
Bimatoprost
32
Restasis
Cyclosporine
23
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
21
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
18
Cyclosporine
16
Brimonidine Tartrate
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How Molly Wood fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

Molly Wood's 391 claims are above the specialty average of 257.

Nearby Optometrist Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Wood.

Compare Optometrist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Pennsylvania medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Molly Wood's specialty?
Molly Wood specializes in Optometrist and practices in State College, Pennsylvania.
How much does Molly Wood prescribe under Medicare Part D?
In 2023, Molly Wood wrote 391 Medicare Part D claims totaling $87K in drug costs for 140 beneficiaries.
What is Molly Wood's Medicare quality score?
Molly Wood has a CMS MIPS Final Score of 73.6/100 (Quality: 100, Cost: 12). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Molly Wood located?
Molly Wood is located at 2581 CLYDE AVE, State College, PA, 16801. Phone: (814) 867-5415.
What is Molly Wood's NPI number?
Molly Wood's National Provider Identifier (NPI) is 1790979102, issued on 08/29/2007.
Does Molly Wood prescribe more brand-name or generic drugs?
Molly Wood's prescribing is 48% brand-name and 52% generic drugs by claim count, with $80K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does Molly Wood prescribe most often?
Based on 2023 Medicare Part D data, Molly Wood's most frequently prescribed drugs include Timolol Maleate, Latanoprost, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Molly Wood accept Medicare?
Molly Wood appears in CMS Medicare data with 391 Part D claims and 140 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Molly Wood's credentials?
Molly Wood's NPI is 1790979102. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology